How Do We Taper and Discontinue Opioids in Cancer Patients? Considerations from the Activities of a Palliative Care Team at a University Hospital-Reference-Cited by-同舟云学术

How Do We Taper and Discontinue Opioids in Cancer Patients? Considerations from the Activities of a Palliative Care Team at a University Hospital

Published:2021-09-01 Issue:1 Volume:2 Page:255-259
ISSN:2689-2820
Container-title:Palliative Medicine Reports
language:en
Short-container-title:Palliative Medicine Reports

Author:

Kihara Ayumi¹,Shimada Kazuki²,Tsuneto Satoru²³

Affiliation:

1. Department of Palliative Medicine, Kyoto Min-iren Asukai Hospital, Kyoto, Japan.

2. Department of Palliative Medicine, Kyoto University Hospital, Kyoto, Japan.

3. Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Publisher

Mary Ann Liebert Inc

Subject

General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/pmr.2020.0105

Reference21 articles.

1. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

2. Pain in Cancer Survivors

3. Pain in cancer survivors; filling in the gaps

4. Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives

5. 5. Oxford Textbook of Palliative Medicine, 5th ed. In: Cherny N, Fallon M, Kaasa S, Portenoy R, Currow DC (eds). New York, NY: Oxford University Press, 2015.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fentanyl/Oxycodone;Reactions Weekly;2024-03-02

2. What types of clinical interventions do pharmacists carry out in hospitals for patients receiving palliative care?;Progress in Palliative Care;2023-12-09